Press Releases Vycor Medical, Inc.

Equities

VYCO

US92921M2035

Delayed OTC Markets Other stock markets 03:52:19 2024-04-09 pm EDT			5-day change	1st Jan Change
0.084 ^USD	-.--%		-.--%	+8.81%

Apr. 16	Vycor Medical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Vycor Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

VYCOR MEDICAL INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION. (form 10-K)	23-04-14	AQ
VYCOR MEDICAL INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	22-11-14	AQ
VYCOR MEDICAL INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	22-08-15	AQ
VYCOR MEDICAL INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	22-05-10	AQ
VYCOR MEDICAL INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION. (form 10-K)	22-04-13	AQ
VYCOR MEDICAL INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	21-11-12	AQ
VYCOR MEDICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	21-08-16	AQ
VYCOR MEDICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	21-05-14	AQ
VYCOR MEDICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION. (form 10-K)	21-03-31	AQ
VYCOR MEDICAL INC : Change in Directors or Principal Officers (form 8-K)	21-03-22	AQ
VYCOR MEDICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	20-11-13	AQ
VYCOR MEDICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	20-08-17	AQ
VYCOR MEDICAL INC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	20-06-30	AQ
Vycor Medical, Inc. Agrees New NovaVision Licensing Agreement	20-06-30	GL
VYCOR MEDICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	20-05-12	AQ
VYCOR MEDICAL INC : Change in Directors or Principal Officers, Results of Operations and Financial Condition (form 8-K)	20-03-27	AQ
Vycor Medical Reports Financial Results for the year ended December 31st, 2019	20-03-27	GL
VYCOR MEDICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION. (form 10-K)	20-03-27	AQ
Vycor Medical : New Study Shows Vision Rehab Treatment Effective for Stroke and Injury Related Blindness	20-02-27	AQ
Vycor Medical : Treatment for blindness successful in largest ever study	20-02-26	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Vycor Medical, Inc.

Equities

VYCO

US92921M2035

Press Releases

Filters